BRAF and differentiated thyroid carcinoma: Besides, the incorporation of molecular markers, such as BRAF, RAS and TERT detection, enhances the diagnostic value of thyroid nodules exhibiting indeterminate cytology (41, 42), and plays a role in predicting outcomes for patients with papillary thyroid carcinoma (43).